NO20000230L - Behandling av diabetes med tiazolidindion, insulin sekretagogue og <alfa>glukosidaseinhibitor - Google Patents

Behandling av diabetes med tiazolidindion, insulin sekretagogue og <alfa>glukosidaseinhibitor

Info

Publication number
NO20000230L
NO20000230L NO20000230A NO20000230A NO20000230L NO 20000230 L NO20000230 L NO 20000230L NO 20000230 A NO20000230 A NO 20000230A NO 20000230 A NO20000230 A NO 20000230A NO 20000230 L NO20000230 L NO 20000230L
Authority
NO
Norway
Prior art keywords
glucosidase inhibitor
thiazolidinedione
alfa
diabetes
treatment
Prior art date
Application number
NO20000230A
Other languages
English (en)
Other versions
NO20000230D0 (no
Inventor
Robin Edwin Buckingham
Stephen Alistair Smith
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO20000230L publication Critical patent/NO20000230L/no
Publication of NO20000230D0 publication Critical patent/NO20000230D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Abstract

Fremgangsmåte for behandling av diabetes mellitus og tilstander knyttet til diabetes mellitus hos et pattedyr, der fremgangsmåten omfatter tilførsel av en effektiv, ikke-toksisk og farmasøytisk akseptabel mengde av en insulinsensitiserende forbindelse, en insulinsekretagogue og en alfa-glukosidaseinhibitor antihyperglykemisk forbindelse, til et pattedyr som har behov for dette, og blanding til bruk i en slik fremgangsmåte.
NO20000230A 1997-07-18 2000-01-17 Behandling av diabetes med tiazolidindion, insulin sekretagogue og <alfa>glukosidaseinhibitor NO20000230D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9715298A GB9715298D0 (en) 1997-07-18 1997-07-18 Novel method of treatment
PCT/GB1998/002112 WO1999003478A1 (en) 1997-07-18 1998-07-16 Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor

Publications (2)

Publication Number Publication Date
NO20000230L true NO20000230L (no) 2000-01-17
NO20000230D0 NO20000230D0 (no) 2000-01-17

Family

ID=10816170

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000230A NO20000230D0 (no) 1997-07-18 2000-01-17 Behandling av diabetes med tiazolidindion, insulin sekretagogue og <alfa>glukosidaseinhibitor

Country Status (27)

Country Link
EP (1) EP1001784A1 (no)
JP (1) JP2001510160A (no)
KR (1) KR20010021952A (no)
CN (1) CN1263467A (no)
AP (1) AP2000001735A0 (no)
AR (2) AR016350A1 (no)
AU (1) AU8449098A (no)
BG (1) BG104062A (no)
BR (1) BR9810292A (no)
CA (1) CA2297133A1 (no)
CO (1) CO4940489A1 (no)
DZ (1) DZ2563A1 (no)
EA (1) EA200000140A1 (no)
GB (1) GB9715298D0 (no)
HU (1) HUP0003626A3 (no)
ID (1) ID23804A (no)
IL (1) IL133907A0 (no)
MA (1) MA24608A1 (no)
NO (1) NO20000230D0 (no)
OA (1) OA11312A (no)
PE (1) PE99499A1 (no)
PL (1) PL338140A1 (no)
SK (1) SK612000A3 (no)
TR (1) TR200000133T2 (no)
UY (1) UY25101A1 (no)
WO (1) WO1999003478A1 (no)
ZA (1) ZA986364B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI238064B (en) * 1995-06-20 2005-08-21 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
ES2291210T3 (es) * 1999-06-21 2008-03-01 Eli Lilly And Company Uso sinergistico de tiazolidindionas con peptido-1 tipo glucagona y sus agonistas para tratar la diabetes no insulina-dependiente.
BRPI0107715B8 (pt) * 2000-01-21 2021-05-25 Novartis Ag produto farmacêutico compreendendo um inibidor de dipeptidilpeptidase-iv e metformina, bem como usos do dito produto farmacêutico e do inibidor de dipeptidilpeptidase-iv
EP1295609A4 (en) * 2000-02-24 2004-11-03 Takeda Chemical Industries Ltd DRUGS CONTAINING COMBINED ACTIVE INGREDIENTS
JP4917712B2 (ja) * 2000-02-24 2012-04-18 武田薬品工業株式会社 併用医薬
JP4633329B2 (ja) 2001-01-12 2011-02-16 サン・ファーマ・アドバンスド・リサーチ・カンパニー・リミテッド スペーストドラッグデリバリーシステム
FR2832930A1 (fr) * 2001-12-03 2003-06-06 Lipha Composition pharmaceutique comprenant un inhibiteur d'alpha-glucosidase et un derive de thiazolidinedione et son utilisation pour la preparation de medicaments destines a traiter le diabete
NZ546337A (en) 2003-10-31 2009-03-31 Takeda Pharmaceutical Solid preparation comprising an insulin sensitizer such as pioglitazone hydrochloride, an insulin secretagogue such as glimepiride and a polyoxyethylene sorbitan fatty acid ester such as Polysorbate 80
CN101103993B (zh) * 2006-07-14 2011-03-30 北京华安佛医药研究中心有限公司 降糖药物组合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2101866T3 (es) * 1991-08-26 1997-07-16 Upjohn Co Producto alimentario liquido que contiene acido 3-guanidinopropionico.
US5917052A (en) * 1994-09-28 1999-06-29 Shaman Pharmaceuticals, Inc. Hypoglycemic agent from cryptolepis
TWI238064B (en) * 1995-06-20 2005-08-21 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes

Also Published As

Publication number Publication date
PL338140A1 (en) 2000-09-25
SK612000A3 (en) 2000-07-11
ZA986364B (en) 2000-01-17
CN1263467A (zh) 2000-08-16
AR016350A1 (es) 2001-07-04
GB9715298D0 (en) 1997-09-24
WO1999003478A1 (en) 1999-01-28
UY25101A1 (es) 2000-12-29
AR019724A2 (es) 2002-03-13
HUP0003626A3 (en) 2001-12-28
BG104062A (en) 2000-11-30
DZ2563A1 (fr) 2003-02-15
TR200000133T2 (tr) 2000-09-21
CO4940489A1 (es) 2000-07-24
ID23804A (id) 2000-05-11
EP1001784A1 (en) 2000-05-24
AU8449098A (en) 1999-02-10
MA24608A1 (fr) 1999-04-01
NO20000230D0 (no) 2000-01-17
IL133907A0 (en) 2001-04-30
PE99499A1 (es) 1999-12-18
KR20010021952A (ko) 2001-03-15
BR9810292A (pt) 2000-09-19
CA2297133A1 (en) 1999-01-28
OA11312A (en) 2003-10-24
JP2001510160A (ja) 2001-07-31
HUP0003626A2 (hu) 2001-05-28
AP2000001735A0 (en) 2000-01-16
EA200000140A1 (ru) 2000-06-26

Similar Documents

Publication Publication Date Title
NO20090846L (no) Kombinasjon og farmasoytisk blanding for behandling av diabetes samt anvendelse derav
EA200300036A1 (ru) Комбинации ингибиторов дипептидилпептидазы iv и других антидиабетических агентов для лечения сахарного диабета
NO970519L (no) Behandling av type II diabetes mellitus med amylinagonister
NO20083276L (no) Behandling av diabetes med tiazolidindion og sulfonylurea
BR0308904A (pt) Método de tratamento de gastroparesia, e, uso de um composto de glp-1
NO20000230L (no) Behandling av diabetes med tiazolidindion, insulin sekretagogue og &lt;alfa&gt;glukosidaseinhibitor
MY155219A (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and biguanide
SE9803760D0 (sv) Sätt att behandla och diagnostisera syndromet restless legs och motsvarande medel
WO2001091774A3 (en) Method of treating chronic ulcers
NO996270L (no) Behandling av diabetes med tiazolidindion og &lt;alfa&gt;- glukosidaseinhibitor
TR199903095T2 (xx) Diabetin roziglitazon ve ins�lin ile tedavisi.
HUP0104388A2 (hu) Béta-agonistákból és további antidiabetikus szerekből álló kombinációk
EA200000141A1 (ru) Способ лечения диабета тиазолидиндионом и сульфонилмочевиной
WO2001047509A3 (en) Composition for the treatment diabetes mellitus containing an insuline sensitizer and agent used in the treatment of cardiac conditions
EA199800177A1 (ru) Способ снижения количества экзогенного инсулина, вводимого пациенту с инсулиннезависимым сахарным диабетом
CO5150158A1 (es) Tratamiento antidiabetico novedoso
ECSP982542A (es) Nuevo metodo de tratamiento iii
TR200000957T2 (tr) Hiperglisemi tedavisinde tiazolidinedion kullanımı
HUP0002569A2 (hu) Diabetes kezelésére alkalmas dioxo-tiazolidint és alfa-glükozidáz inhibitort tartalmazó gyógyszerkészítmények
ECSP982593A (es) Nuevo metodo de tratamiento vi
ECSP982534A (es) Nuevo metodo de tratamiento
TR200000958T2 (tr) Hiperglisemi tedavisinde tiazolidinedion kullanımı.
ECSP982535A (es) Nuevo metodo de tratamiento (i)

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application